Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions

NCT04684602 is registered in ClinicalTrials.gov with Thomas Advanced Medical LLC as lead sponsor.

NCT NCT04684602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04684602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions
Lead sponsor
Thomas Advanced Medical LLC
Phase
Phase 1/2
Overall status
Recruiting
Start date
July 9, 2020
Completion date
December 9, 2030
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, cardiovascular disorders, diabetes complications, integumentary disease, musculoskeletal disorders, neurodegenerative disorders, neurologic disorders, pulmonary disorders, sexual dysfunction, urologic disorders, viral illness